Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer

Anlotinib is a multitargeted antiangiogenic drug, and its clinical predictor for responsive non‐small cell lung cancer (NSCLC) patients is still elusive. Here, tumor‐specific target capture is used to profile the circulating DNA of ALTER0303 (evaluating NSCLC clinical antitumor efficacy through anlo...

全面介紹

Na minha lista:
書目詳細資料
發表在:Adv Sci (Weinh)
Main Authors: Lu, Jun, Zhong, Hua, Wu, Jun, Chu, Tianqing, Zhang, Lele, Li, Hua, Wang, Qiming, Li, Rong, Zhao, Yizhuo, Gu, Aiqin, Wang, Huimin, Shi, Chunlei, Xiong, Liwen, Zhang, Xueyan, Zhang, Wei, Lou, Yuqing, Yan, Bo, Dong, Yu, Zhang, Yanwei, Li, Baolan, Zhang, Li, Zhao, Xiaodong, Li, Kai, Han, Baohui
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2019
主題:
Full Papers
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6774020/
https://ncbi.nlm.nih.gov/pubmed/31592412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.201900721
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍